Home CHANGCHUN HIGH-TECH: Leuprorelin Mesilate Injection (6M) Marketing Application Accepted by NMPA

CHANGCHUN HIGH-TECH: Leuprorelin Mesilate Injection (6M) Marketing Application Accepted by NMPA

May 29, 2026 17:45 CST Updated 18:11
CHANGCHUN HIGH-TECH

Pharmaceutical R&D Developer

GenSci

Gene Engineering Pharmaceutical and Growth Hormone Producer